Shingo Fujio

DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors

T Hirohata, Kenichiro Asano, Yoshikazu Ogawa et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 122 citations · Full text

Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae

Yuriz Bakhtiar, Hirofumi Hirano, Kazunori Arita et al. · European Journal of Endocrinology · 2010 · 87 citations

DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome

Tareq A. Juratli, Devin McCabe, Naema Nayyar et al. · Acta Neuropathologica · 2018 · 80 citations

Mendelian Disorder, Poor Outcome, Dmd Genomic Deletions +6

A tailored next‐generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas

Nayuta Higa, Toshiaki Akahane, Seiya Yokoyama et al. · Cancer Science · 2020 · 51 citations · Full text

A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas

Shingo Fujio, Tareq A. Juratli, Kazunori Arita et al. · Neurosurgery · 2018 · 42 citations · Full text